Evidence map›Paper›PMID 34167488›Full record

ArticleBMC neurology2021

Next-generation sequencing combined with serological tests based pathogen analysis for a neurocysticercosis patient with a 20-year history:a case report.

Bin Chen, Zheng Chen, Yi-Shu Yang, Gui-Lan Cai, Xiao-Jiao Xu, Hong-Zhi Guan, Hai-Tao Ren, Hou-Zhen Tuo

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Bin ChenDepartment of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Zheng ChenDepartment of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Yi-Shu YangDepartment of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Gui-Lan CaiDepartment of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Xiao-Jiao XuDepartment of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Hong-Zhi GuanDepartment of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Hai-Tao RenDepartment of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Hou-Zhen TuoDepartment of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing, China. tuohzh@sina.cn.
Capital Medical University · CNBeijing Friendship Hospital · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNPeking Union Medical College Hospital · CN

Funding

National Natural Science Foundation of China 81801334
6 · The paper itself

Abstract

backgroundNeurocysticercosis (NCC) is the most common helminthic infection of the central nervous system (CNS) caused by the larval stage of Taenia solium. Accurate and early diagnosis of NCC remains challenging due to its heterogeneous clinical manifestations, neuroimaging deficits, variable sensitivity, and specificity of serological tests. Next-generation sequencing (NGS)-based pathogen analysis in patient's cerebrospinal fluid (CSF) with NCC infection has recently been reported indicating its diagnostic efficacy. In this case study, we report the diagnosis of a NCC patient with a symptomatic history of over 20 years using NGS analysis and further confirmation of the pathology by immunological tests. CASE PRESENTATION: This study reports the clinical imaging and immunological features of a patient with a recurrent headache for more than 20 years, which worsened gradually with the symptom of fever for more than 7 years and paroxysmal amaurosis for more than 1 year. By utilizing NGS technique, the pathogen was detected in patient's CSF, and the presence of Taenia solium-DNA was confirmed by a positive immunological reaction to cysticercus IgG antibody in CSF and serum samples. The symptoms of the patient were alleviated, and the CSF condition was improved substantially after the anti-helminthic treatment.

conclusionsThis study suggests that combining CSF NGS with cysticercus IgG testing may be a highly promising approach for diagnosing the challenging cases of NCC. Further studies are needed to evaluate the parasitic DNA load in patients' CSF for the diagnosis of disease severity, stage, and monitoring of therapeutic responses.

Indexed as

High-Throughput Nucleotide SequencingNeurocysticercosisSerologic TestsTaenia soliumAnimalsAntibodies, HelminthDNA, HelminthHumansMolecular Diagnostic TechniquesAntibodies, HelminthDNA, HelminthAmaurosisCase reportCysticercus IgGHeadacheLong historyNeurocysticercosisNext-generation sequencingTaenia solium

Identifiers

PMID34167488
PMCPMC8222500
OpenAlexW3176458196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.